Sahm Adrangi is an entrepreneur who founded his own company in the financial industry. This company is Kerrisdale Capital Management LLC and it is based in New York, New York. His company, for which he is the chief investment officer, operates a hedge fund. He tends to focus on a couple of sectors in the economy such as telecommunications and healthcare. Read more at Endpoints News about Sahm Adrangi.
After Sahm Adrangi and his team of analysts do their due research on a company he might either short the business’ stock or go long depending on his views. In recent months a major focus of his hedge fund has been on biotechnology companies. He did research on a couple of company and the drugs they had in pre-clinical stages of development. Some of them, like Bavarian Nordic, he spotted that their highly-anticipated drugs were definitely not going to pan out. In Bavarian Nordic’s case they were working on a cancer vaccine. Sahm Adgrangi was right the vaccine showed zero promise when it turned out that it didn’t work any better than a placebo did.
Another biotechnology Sahm Adrangi developed a dim view of was Prothena which ad been worth over $2 billion. They had a drug called AL amyloidosis that was also in a preclinical stage of development. He developed information that the drug was useless and predicted that both its Phase IIb and Phase III studies would bear this information out. As he said it, it was clear to him the drug had zero chance of success.
Sahm Adrangi graduated from college in 2003 with an economics degree. Once out of college he got a job as an analyst for Deutsche Bank. This led to two other analyst positions for two other Wall Street financial firms, Chanin Capital Partners and Longacre Fund Management LLC. He launched Kerrisdale when he was in his late 20’s. His earliest successes occurred when he spotted that a collection of Chinese companies were scams and after shorting their stock he revealed this information to other investors. These Chinese companies US-based stocks tanked and his shorting them paid off very well. Read more at nymag.com about Sahm Adrangi.